Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis

Background: Vascular smooth muscle cells (VSMCs) are involved in atherosclerotic plaque development. The formation of VSMC-originated foam cells, phenotypic switching, and VSMC proliferation, migration, apoptosis, and autophagy play different roles in atherosclerosis (AS)....

Full description

Saved in:
Bibliographic Details
Main Authors: Lingna Zhao, Li Zhao, Deshen Liu, Fangze Huang, Qinbao Peng, Jun Lu, Jiaguo Zhou, Shaoyi Zheng, Xiu Liu
Format: Article
Language:English
Published: IMR Press 2025-06-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/26/6/10.31083/RCM28240
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850089029414944768
author Lingna Zhao
Li Zhao
Deshen Liu
Fangze Huang
Qinbao Peng
Jun Lu
Jiaguo Zhou
Shaoyi Zheng
Xiu Liu
author_facet Lingna Zhao
Li Zhao
Deshen Liu
Fangze Huang
Qinbao Peng
Jun Lu
Jiaguo Zhou
Shaoyi Zheng
Xiu Liu
author_sort Lingna Zhao
collection DOAJ
description Background: Vascular smooth muscle cells (VSMCs) are involved in atherosclerotic plaque development. The formation of VSMC-originated foam cells, phenotypic switching, and VSMC proliferation, migration, apoptosis, and autophagy play different roles in atherosclerosis (AS). Main Body: Foam cell formation promotes the generation and evolution of atherosclerotic plaques. The VSMC phenotype, switching from contractile to other forms, is important in the formation and progression of AS. VSMC proliferation, migration, and apoptosis affect the stability of atherosclerotic plaques through the fibrous cap. VSMC proliferation and migration can increase the thickness of the fibrous cap of the plaques, which protects plaques from rupture and is beneficial for slowing the occurrence of advanced lesions. However, apoptosis can accelerate plaque rupturing and trigger severe cardiovascular disease. The autophagy of VSMCs has a protective influence on safeguarding cellular homeostasis in the early stages of AS. However, increased autophagy of VSMCs in the late stages of AS can lead to cell death, thereby affecting the stability of late-stage plaques. This review comprehensively reviews recent research on genetic proteins and mechanisms influencing various aspects of VSMCs, including VSMC-derived foam cells, phenotypic switching, proliferation, migration, apoptosis, and autophagy. Additionally, this review aimed to examine the implications of VSMCs for AS and discussed several regulators that can impact the progression of this condition. Our review thoroughly summarizes the latest research developments in this field. Conclusion: Based on the vital role of VSMCs in AS, this review provides an overview of the latest factors and mechanisms based on VSMC-derived foam cells, phenotype switching, proliferation, migration, apoptosis, and autophagy. The review also introduces certain regulators that can inhibit the development of AS. An understanding of the role of VSMCs aids in identifying new targets and directions for advancing innovative anti-atherosclerotic therapeutic regimens and provides new insights into the development of treatments for AS.
format Article
id doaj-art-99fc8d2bdd7c4effa69fbeb8ae901599
institution DOAJ
issn 1530-6550
language English
publishDate 2025-06-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj-art-99fc8d2bdd7c4effa69fbeb8ae9015992025-08-20T02:42:53ZengIMR PressReviews in Cardiovascular Medicine1530-65502025-06-012662824010.31083/RCM28240S1530-6550(25)01795-8Vascular Smooth Muscle Cells: A Therapeutic Target in AtherosclerosisLingna Zhao0Li Zhao1Deshen Liu2Fangze Huang3Qinbao Peng4Jun Lu5Jiaguo Zhou6Shaoyi Zheng7Xiu Liu8Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaDepartment of Pharmacology, Cardiac and Cerebral Vascular Research Center, Zhongshan School of Medicine, Sun Yat-sen University, 510080 Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, Guangdong, ChinaBackground: Vascular smooth muscle cells (VSMCs) are involved in atherosclerotic plaque development. The formation of VSMC-originated foam cells, phenotypic switching, and VSMC proliferation, migration, apoptosis, and autophagy play different roles in atherosclerosis (AS). Main Body: Foam cell formation promotes the generation and evolution of atherosclerotic plaques. The VSMC phenotype, switching from contractile to other forms, is important in the formation and progression of AS. VSMC proliferation, migration, and apoptosis affect the stability of atherosclerotic plaques through the fibrous cap. VSMC proliferation and migration can increase the thickness of the fibrous cap of the plaques, which protects plaques from rupture and is beneficial for slowing the occurrence of advanced lesions. However, apoptosis can accelerate plaque rupturing and trigger severe cardiovascular disease. The autophagy of VSMCs has a protective influence on safeguarding cellular homeostasis in the early stages of AS. However, increased autophagy of VSMCs in the late stages of AS can lead to cell death, thereby affecting the stability of late-stage plaques. This review comprehensively reviews recent research on genetic proteins and mechanisms influencing various aspects of VSMCs, including VSMC-derived foam cells, phenotypic switching, proliferation, migration, apoptosis, and autophagy. Additionally, this review aimed to examine the implications of VSMCs for AS and discussed several regulators that can impact the progression of this condition. Our review thoroughly summarizes the latest research developments in this field. Conclusion: Based on the vital role of VSMCs in AS, this review provides an overview of the latest factors and mechanisms based on VSMC-derived foam cells, phenotype switching, proliferation, migration, apoptosis, and autophagy. The review also introduces certain regulators that can inhibit the development of AS. An understanding of the role of VSMCs aids in identifying new targets and directions for advancing innovative anti-atherosclerotic therapeutic regimens and provides new insights into the development of treatments for AS.https://www.imrpress.com/journal/RCM/26/6/10.31083/RCM28240atherosclerosisvascular smooth muscle cellvascular smooth muscle cell-derived foam cellphenotypic switchingapoptosisautophagy
spellingShingle Lingna Zhao
Li Zhao
Deshen Liu
Fangze Huang
Qinbao Peng
Jun Lu
Jiaguo Zhou
Shaoyi Zheng
Xiu Liu
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
Reviews in Cardiovascular Medicine
atherosclerosis
vascular smooth muscle cell
vascular smooth muscle cell-derived foam cell
phenotypic switching
apoptosis
autophagy
title Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
title_full Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
title_fullStr Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
title_full_unstemmed Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
title_short Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
title_sort vascular smooth muscle cells a therapeutic target in atherosclerosis
topic atherosclerosis
vascular smooth muscle cell
vascular smooth muscle cell-derived foam cell
phenotypic switching
apoptosis
autophagy
url https://www.imrpress.com/journal/RCM/26/6/10.31083/RCM28240
work_keys_str_mv AT lingnazhao vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT lizhao vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT deshenliu vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT fangzehuang vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT qinbaopeng vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT junlu vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT jiaguozhou vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT shaoyizheng vascularsmoothmusclecellsatherapeutictargetinatherosclerosis
AT xiuliu vascularsmoothmusclecellsatherapeutictargetinatherosclerosis